These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16477528)

  • 1. Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers.
    González-Mariscal L; Nava P; Hernández S
    J Membr Biol; 2005 Sep; 207(2):55-68. PubMed ID: 16477528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inventions designed to enhance drug delivery across epithelial and endothelial cells through the paracellular pathway.
    Gonzalez-Mariscal L; Hernández S; Vega J
    Recent Pat Drug Deliv Formul; 2008; 2(2):145-76. PubMed ID: 19075905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.
    Deli MA
    Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies that Target Tight Junctions for Enhanced Drug Delivery.
    González-Mariscal L; Posadas Y; Miranda J; Uc PY; Ortega-Olvera JM; Hernández S
    Curr Pharm Des; 2016; 22(35):5313-5346. PubMed ID: 27510485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of intestinal permeability: interaction at tight junctions.
    Hossain Z; Hirata T
    Mol Biosyst; 2008 Dec; 4(12):1181-5. PubMed ID: 19396381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junctions: facts and models.
    Dunina-Barkovskaya A
    Membr Cell Biol; 1998; 11(5):555-89. PubMed ID: 9672876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability.
    Balkovetz DF
    Am J Physiol Renal Physiol; 2006 Mar; 290(3):F572-9. PubMed ID: 16461756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tight junctional permeability is associated with the development of colon cancer.
    Soler AP; Miller RD; Laughlin KV; Carp NZ; Klurfeld DM; Mullin JM
    Carcinogenesis; 1999 Aug; 20(8):1425-31. PubMed ID: 10426787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Barriology-based strategy for drug absorption].
    Kondoh M; Fujii M; Yagi K; Watanabe Y
    Yakugaku Zasshi; 2007 Apr; 127(4):601-9. PubMed ID: 17409689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tight junction proteins-significance for drug development.
    Kondoh M; Yoshida T; Kakutani H; Yagi K
    Drug Discov Today; 2008 Feb; 13(3-4):180-6. PubMed ID: 18275916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tight junction: morphology to molecules.
    Stevenson BR; Keon BH
    Annu Rev Cell Dev Biol; 1998; 14():89-109. PubMed ID: 9891779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological changes in tight junctions and potential applications into therapies.
    Takahashi A; Kondoh M; Suzuki H; Watari A; Yagi K
    Drug Discov Today; 2012 Jul; 17(13-14):727-32. PubMed ID: 22414542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells.
    Del Vecchio G; Tscheik C; Tenz K; Helms HC; Winkler L; Blasig R; Blasig IE
    Mol Pharm; 2012 Sep; 9(9):2523-33. PubMed ID: 22827574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone and tight junctions: modulation of claudin-4 phosphorylation in renal collecting duct cells.
    Le Moellic C; Boulkroun S; González-Nunez D; Dublineau I; Cluzeaud F; Fay M; Blot-Chabaud M; Farman N
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1513-21. PubMed ID: 16107502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells.
    Nava P; López S; Arias CF; Islas S; González-Mariscal L
    J Cell Sci; 2004 Nov; 117(Pt 23):5509-19. PubMed ID: 15494377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight junction-based epithelial microenvironment and cell proliferation.
    Tsukita S; Yamazaki Y; Katsuno T; Tamura A; Tsukita S
    Oncogene; 2008 Nov; 27(55):6930-8. PubMed ID: 19029935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization.
    Mullin JM; Soler AP; Laughlin KV; Kampherstein JA; Russo LM; Saladik DT; George K; Shurina RD; O'Brien TG
    Exp Cell Res; 1996 Aug; 227(1):12-22. PubMed ID: 8806446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tight junction modulation and its relationship to drug delivery.
    Salama NN; Eddington ND; Fasano A
    Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation.
    Gonzalez-Mariscal L; Nava P
    Adv Drug Deliv Rev; 2005 Apr; 57(6):811-4. PubMed ID: 15820554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.